Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP08742677.1Aexternal-prioritypatent/EP2139484B9/en
Application filed by Exelixis, Inc.filedCriticalExelixis, Inc.
Publication of CY1114609T1publicationCriticalpatent/CY1114609T1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Η παρούσα εφεύρεση παρέχει μεθόδους θεραπείας καρκίνου με χορήγηση Ένωσης του Τύπου Ι, προαιρετικώς ως φαρμακευτικώς αποδεκτό άλας, διαλύτωμα ή/και υδρίτη αυτής, σε συνδυασμό με άλλες θεραπείες καρκίνου.The present invention provides methods of treating cancer by administering a Compound of Formula I, optionally as a pharmaceutically acceptable salt, solvate and / or hydrate thereof, in combination with other cancer therapies.
CY20131100805T2007-04-102013-09-18
METHODS OF CANCER TREATMENT USING P13K ALPHA PYRIDOPYRIMIDINONIS
CY1114609T1
(en)